Surface layer protein A variant of Clostridium difficile PCR-ribotype 027

Emerg Infect Dis. 2011 Feb;17(2):317-9. doi: 10.3201/eid1702.100355.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Aza Compounds / pharmacology
  • Bacterial Proteins / genetics*
  • Canada / epidemiology
  • Clostridioides difficile / classification*
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / genetics
  • Clostridioides difficile / isolation & purification
  • Drug Resistance, Bacterial
  • Enterocolitis, Pseudomembranous / epidemiology*
  • Enterocolitis, Pseudomembranous / microbiology*
  • Epidemics
  • Erythromycin / pharmacology
  • Europe / epidemiology
  • Fluoroquinolones
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Phylogeny
  • Polymerase Chain Reaction / methods*
  • Quinolines / pharmacology
  • Ribotyping*
  • Sequence Analysis, DNA
  • Virulence / genetics

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Bacterial Proteins
  • Fluoroquinolones
  • Quinolines
  • surface layer protein A, Bacteria
  • Erythromycin
  • Moxifloxacin